115 related articles for article (PubMed ID: 1383627)
1. Cardiac and hemodynamic effects of intravenous R80122, a new phosphodiesterase III inhibitor, in a canine model of myocardial ischemia and heart failure.
Van de Water A; Xhonneux R; Reneman RS; Janssen PA
J Cardiovasc Pharmacol; 1992 Jul; 20(1):18-24. PubMed ID: 1383627
[TBL] [Abstract][Full Text] [Related]
2. Comparative effects of R 80122, enoximone, and milrinone on left ventricular phosphodiesterase isoenzymes in vitro and on contractility of normal and stunned myocardium in vivo in dogs.
Vandeplassche GM; Hermans CF; de Chaffoy de Courcelles DR; D'Aubioul JA; Wouters LJ; De Clerck FF
J Cardiovasc Pharmacol; 1992 May; 19(5):714-22. PubMed ID: 1381769
[TBL] [Abstract][Full Text] [Related]
3. [Effects of R80122. The influence of a new phosphodiesterase inhibitor on global and intestinal hemodynamics in coronary surgery patients].
Lange H; Stephan H; Autschbach R; Lueerssen K; Zielmann S; Sonntag H
Anaesthesist; 1992 Aug; 41(8):474-80. PubMed ID: 1524159
[TBL] [Abstract][Full Text] [Related]
4. [Hemodynamic effects of milrinone in the treatment of cardiac insufficiency after heart surgery with extracorporeal circulation].
Lançon JP; Caillard B; Obadia JF; Pillet M; Leblanc-Beaufils C; Le Bloch Y
Arch Mal Coeur Vaiss; 1991 Nov; 84(11):1575-9. PubMed ID: 1763924
[TBL] [Abstract][Full Text] [Related]
5. Effect of bolus milrinone on hemodynamic variables and pulmonary vascular resistance in patients with severe left ventricular dysfunction: a rapid test for reversibility of pulmonary hypertension.
Givertz MM; Hare JM; Loh E; Gauthier DF; Colucci WS
J Am Coll Cardiol; 1996 Dec; 28(7):1775-80. PubMed ID: 8962566
[TBL] [Abstract][Full Text] [Related]
6. Peripheral and cardiac effects of a new phosphodiesterase inhibitor in comparison with enoximone.
Schröder T; Hering JP; Foth H; Ferrari M; Sipinková I; Hellige G
Arzneimittelforschung; 1994 Aug; 44(8):948-50. PubMed ID: 7945538
[TBL] [Abstract][Full Text] [Related]
7. Milrinone in the treatment of low output states following cardiac surgery.
Wright EM; Skoyles J; Sherry KM
Eur J Anaesthesiol Suppl; 1992; 5():21-6. PubMed ID: 1600964
[TBL] [Abstract][Full Text] [Related]
8. Haemodynamic and biological effects of intravenous milrinone in patients with a low cardiac output syndrome following cardiac surgery: multicentre study.
George M; Lehot JJ; Estanove S
Eur J Anaesthesiol Suppl; 1992; 5():31-4. PubMed ID: 1600967
[TBL] [Abstract][Full Text] [Related]
9. Pharmacologic and pharmacodynamic effects of the selective low Km cyclic AMP phosphodiesterase III inhibitors WIN 63291 and WIN 62582.
Pagani ED; Dundore RL; Bode DC; Bacon ER; Singh B; Lesher GY; Buchholz RA; Silver PJ
J Cardiovasc Pharmacol; 1994 Sep; 24(3):403-10. PubMed ID: 7528296
[TBL] [Abstract][Full Text] [Related]
10. Hemodynamic and inotropic effects of milrinone after heart transplantation in the setting of recipient pulmonary hypertension.
Chen EP; Bittner HB; Davis RD; Van Trigt P
J Heart Lung Transplant; 1998 Jul; 17(7):669-78. PubMed ID: 9703231
[TBL] [Abstract][Full Text] [Related]
11. Acute hemodynamic effects of intravenous sildenafil citrate in congestive heart failure: comparison of phosphodiesterase type-3 and -5 inhibition.
Botha P; Parry G; Dark JH; Macgowan GA
J Heart Lung Transplant; 2009 Jul; 28(7):676-82. PubMed ID: 19560695
[TBL] [Abstract][Full Text] [Related]
12. Cardiac and hemodynamic effects of intravenous R 80122, a new phosphodiesterase III inhibitor, in anesthetized and awake dogs.
Van de Water A; d'Aubioul J; Van Gerven W; de Chaffoy de Courcelles D; Freyne E; Xhonneux R; Reneman RS; Janssen PA
Arch Int Pharmacodyn Ther; 1992; 316():60-74. PubMed ID: 1530374
[TBL] [Abstract][Full Text] [Related]
13. Administration of milrinone before ischemia, in the presence of beta-blockade, to treat metabolic impairment and myocardial stunning in pigs.
Sidi A; Muehlschlegel JD; Kirby DS; Lobato EB
Acta Anaesthesiol Scand; 2008 Mar; 52(3):397-405. PubMed ID: 18269389
[TBL] [Abstract][Full Text] [Related]
14. [Hemodynamic effects of new phosphodiesterase inhibitors in patients with coronary heart disease. A comparison between enoximone and R80122].
Kazmaier S; Stephan H; Sonntag H
Anaesthesist; 1995 Jun; 44(6):410-6. PubMed ID: 7653792
[TBL] [Abstract][Full Text] [Related]
15. Milrinone and dobutamine in severe heart failure: differing hemodynamic effects and individual patient responsiveness.
Colucci WS; Wright RF; Jaski BE; Fifer MA; Braunwald E
Circulation; 1986 Mar; 73(3 Pt 2):III175-83. PubMed ID: 3510774
[TBL] [Abstract][Full Text] [Related]
16. [Differences in hemodynamic effects of amrinone, milrinone and olprinon after cardiopulmonary bypass in valvular cardiac surgery].
Sha K; Shimokawa M; Ishimaru K; Kawaraguchi Y; Takahashi M; Yanaidani F; Kitaguchi K; Furuya H
Masui; 2000 Sep; 49(9):981-6. PubMed ID: 11025952
[TBL] [Abstract][Full Text] [Related]
17. Effects of dopamine and olprinone on ventricular energetics in sevoflurane-induced acute left ventricular depression in dogs.
Iwade M; Nomura M; Uezono S; Ashikari E; Ozaki M
J Cardiothorac Vasc Anesth; 2006 Jun; 20(3):358-63. PubMed ID: 16750736
[TBL] [Abstract][Full Text] [Related]
18. A Canadian multicentre study of a 48 h infusion of milrinone in patients with severe heart failure.
Pflugfelder PW; O'Neill BJ; Ogilvie RI; Beanlands DS; Tanser PH; Tihal H; Mizgala HF; Fitchett DH; Kostuk WJ
Can J Cardiol; 1991; 7(1):5-10. PubMed ID: 2025794
[TBL] [Abstract][Full Text] [Related]
19. The inotropic and hemodynamic effects of intravenous milrinone when reflex adrenergic stimulation is suppressed by beta-adrenergic blockade.
Travill CM; Pugh S; Noble MI
Clin Ther; 1994; 16(5):783-92. PubMed ID: 7859237
[TBL] [Abstract][Full Text] [Related]
20. Milrinone: systemic and pulmonary hemodynamic effects in neonates after cardiac surgery.
Chang AC; Atz AM; Wernovsky G; Burke RP; Wessel DL
Crit Care Med; 1995 Nov; 23(11):1907-14. PubMed ID: 7587268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
